Clinical Trials on Cardiovascular System
Total 226649 results
-
Ottawa Heart Institute Research CorporationCompletedCardiovascular DiseaseCanada
-
Boston UniversityCompleted
-
The George Institute for Global Health, ChinaCompleted
-
University of ReadingBiotechnology and Biological Sciences Research Council; Quercegen PharmaceuticalsWithdrawnCardiovascular DiseaseUnited Kingdom
-
Shiraz University of Medical SciencesIslamic Azad University, ShirazCompleted
-
Chalmers University of TechnologyOy Foodfiles LtdCompletedCardiovascular Disease
-
Arstasis, Inc.UnknownCardiovascular Disease.United States
-
Ruijin HospitalUnknownCardiovascular Disease
-
National University Hospital, SingaporeNational University of SingaporeUnknownCardiovascular DiseaseSingapore
-
Arizona State UniversityCompletedCardiovascular DiseaseUnited States
-
Quadram Institute BioscienceUniversity of East Anglia; Clinical Research and Trials Unit (Norfolk & Norwich...Completed
-
Federal University of São PauloCompletedCardiovascular DiseaseBrazil
-
Northwell HealthStaten Island University HospitalCompletedCardiovascular DiseaseUnited States
-
Boston Medical CenterUniversity of Rhode IslandCompleted
-
Laval UniversityDairy Farmers of Canada; Dairy Australia; Institute of Nutraceuticals and Functional...CompletedCardiovascular DiseaseCanada
-
Laval UniversityDairy Farmers of CanadaCompletedCardiovascular DiseaseCanada
-
BioLineRx, Ltd.Sheba Medical CenterUnknown
-
Essentia HealthCompletedCardiovascular DiseaseUnited States
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, France; GIS Institut...CompletedCardiovascular DiseaseFrance
-
Icahn School of Medicine at Mount SinaiAbbott Medical DevicesCompletedCardiovascular DiseaseUnited States
-
Geisinger ClinicAgency for Healthcare Research and Quality (AHRQ)CompletedCardiovascular DiseaseUnited States
-
Mayo ClinicTerminatedCardiovascular DiseaseUnited States
-
Cambridge Theranostics LtdCompletedCardiovascular DiseaseUnited Kingdom
-
Dallas VA Medical CenterUnknownCardiovascular DiseaseUnited States
-
Danone Institute InternationalUnknown
-
University of North Carolina, Chapel HillCenters for Disease Control and Prevention; North Carolina Department of Health...Completed
-
University of FlorenceUnknownCardiovascular DiseaseItaly
-
AstraZenecaCompletedCardiovascular DiseaseFrance, United States, Canada
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedCardiovascular DiseaseUnited States
-
Saitama Medical UniversityCompleted
-
Novartis PharmaceuticalsCompletedAtherosclerotic Cardiovascular DiseaseFrance
-
National Taiwan University HospitalRecruitingStroke, CardiovascularTaiwan
-
Kaohsiung Medical University Chung-Ho Memorial...CompletedStroke, CardiovascularTaiwan
-
St. Justine's HospitalSuspendedType 1 Diabetes | Cardiovascular Risk FactorCanada
-
Istanbul University - Cerrahpasa (IUC)CompletedStroke, CardiovascularTurkey
-
Cairo UniversityKasr El Aini HospitalCompletedStroke, CardiovascularEgypt
-
IRCCS Policlinico S. DonatoUniversity of MilanRecruiting
-
Nanowear Inc.Milton S. Hershey Medical Center; Hackensack Meridian HealthRecruiting
-
National Taiwan University HospitalRecruitingMultichannel ECG SystemTaiwan
-
University of ArkansasCompletedHeart FailureUnited States
-
University of NebraskaWithdrawn
-
Boston Scientific CorporationBTG International Inc.Completed
-
VA Office of Research and DevelopmentCompletedStroke | HypertensionUnited States
-
Baxter Healthcare CorporationCompleted
-
Massachusetts General HospitalCompletedHeart FailureUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHeart Diseases | Cardiovascular Diseases
-
Radiometer Medical ApSCompleted
-
Novartis PharmaceuticalsTerminatedCardiovascular EventsColombia, India, South Africa, Canada, Spain, Hungary, United States, Germany, Ireland, Argentina, Philippines, Brazil, Sweden, Malaysia, Chile, Israel, Czech Republic, Netherlands
-
Helsinki University Central HospitalCompletedVenous InsufficiencyFinland
-
AmgenCompletedA Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CCX168 in Healthy ParticipantsVasculitis | Systemic Lupus Erythematosus (SLE)Switzerland